Jean-Marc Classe, MD PhD; ASCO 2026: Timing of Surgery for Advanced Ovarian Cancer among Neoadjuvant and Adjuvant Chemotherapy Cycles: Early Findings from Randomized CHRONO Trial
About this episode
An interview with Jean-Marc Classe discussing the timing of surgery for advanced ovarian cancer based on early findings from the CHRONO trial.
Timing of Surgery for Advanced Ovarian Cancer among Neoadjuvant and Adjuvant Chemotherapy Cycles: Early Findings from Randomized CHRONO Trial An interview with: Jean-Marc Classe, MD PhD, Surgeon in Gy
People in this episode
Guest: Jean-Marc Classe, MD PhD
Topics covered
- Ovarian Cancer
- Surgery Timing
- Neoadjuvant Chemotherapy
- Adjuvant Chemotherapy
- Clinical Trials
- Oncology
Keywords
- Ovarian Cancer
- Surgery
- Neoadjuvant Chemotherapy
- Adjuvant Chemotherapy
- CHRONO Trial
- Oncology
- Clinical Research
Mentioned in this episode
Organizations: ASCO
Books & works: Timing of Surgery for Advanced Ovarian Cancer among Neoadjuvant and Adjuvant Chemotherapy Cycles
More episodes of Audio Journal of Oncology Podcast
- Kevin Kalinsky MD; ASCO 2026: ASCENT-04 Study Finds Sacituzumab Govitecan plus Pembrolizumab Helps Patients with Previously Untreated Metastatic PD-L1 Positive Triple Negative Breast Cancer Live Longer Without Progression Beyond Subsequent Therapies
- Wing-Lok Chan MBBS; 2026 ASCO: Patients with Advanced Cancer Using The SUPPORT+ Mobile Phone App With Nurse Supervision have Better Quality of Life and Fewer Hospitalizations
- Ghassan K. Abou-Alfa MD PhD; ASCO 2026: Adding Doublet Immune Checkpoint Inhibition to Embolization with or without anti-Growth Factor TKI Therapy Extends Progression Free Survival in Patients with Hepatocellular Cancer
- Jonathan W. Goldman MD and David R Spigel MD; ASCO 2026: Patients with RET Fusion Positive Early Stage Non-Small Cell Lung Cancer Benefit from Selpercatinib: LIBRETTO-432 Early Results
- Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma
- Jana de Boniface MD PhD; ASCO 2026: Omitting Axillary Lymph Node Dissection is Safe for Patients with Breast Cancer Macrometastases to One or Two Sentinel Lymph Nodes
Explore listener stats, chart rankings, contacts and more on the Audio Journal of Oncology Podcast podcast page.